Administering CINQAIR.
Help eligible, commercially insured patients save on out-of-pocket costs for CINQAIR*
A program supporting CINQAIR® (reslizumab) Injection patients
CINQAIR® (reslizumab) Injection – About Asthma Control
CINQAIR - Teva Pharmaceutical Industries Limited Trademark Registration
Flopped trials dash Teva's hopes of battling GSK, AZ with subcutaneous Cinqair | Fierce Pharma
Subcutaneous Cinqair results add to Teva's troubles
Teva Support Solutions ® provides comprehensive access and affordability support for you and your patients
CINQAIR® (reslizumab) Injection - Savings and Support
761033Orig1s000
Teva gets EU nod for severe asthma drug Cinqaero - PMLiVE
including co-pays, co-insurance, and deductibles.*
CINQAIR® (reslizumab) Injection – About CINQAIR
video-placeholder-01.png
Cinqair Reslizumab Injection
Israeli Pharma gets FDA Approval for Asthma Antibody
FDA Approves Cinqair To Treat Severe Asthma - Pharmacy Practice News
CINQAIR® (reslizumab) Injection – About Asthma Control
Reslizumab | New Drug Approvals
Reslizumab (Cinqair) Approved to Treat Severe Asthma | RT
Cinqair (reslizumab) Injection for treatment of Severe Asthma and an Eosinophilic Phenotype - Clinical Trials Arena
Cinqair (reslizumab)- Asthma- by Saro Arakelians, PharmD- Episode # 123 - YouTube
Cinqair: Package Insert - Drugs.com
Medication Detail
New Drug Product: Cinqair - MPR
Product Monograph Template - Schedule D]
